The contribution of health services research to improved dermatologic care

Journal of Investigative Dermatology

Volumn 132, Issue 3 PART 2, 2012, Pages 1003-1007

  Chren, Mary Margaret ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIORAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DERMATOLOGY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH SERVICES RESEARCH; HUMAN; LEADERSHIP; OUTCOME ASSESSMENT; POLITICS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN CARE; TELEDERMATOLOGY;

EID: 84856853376     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.357     Document Type: Review

References (50)

1. AHRQ (2002) Helping the Nation with Health Services Research. Fact Sheet. /http://www.ahrq.gov/news/focus/scenarios.htmS Accessed 30 June 2011
2. Armstrong AW, Idriss N, Bergman H (2009) Physician workforce for acne care in the United States, 2003 through 2005. Arch Dermatol 145: 1195-6
3. Asgari MM, Bertenthal D, Sen S et al. (2009) Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg 35:1041-9
4. Balch CM, Gershenwald JE, Soong SJ et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-206
5. CBSNews (2009) Transcript: Obama's News Conference. /http://www.cbsnews. com/stories/2009/07/23/politics/main5182101.shtmlS Accessed 29 June 2011
6. Chen SC, Bayoumi AM, Soon SL et al. (2004) A catalog of dermatology utilities: A measure of the burden of skin diseases. J Investig Dermatol Symp Proc 9:160-8 (Pubitemid 38457275)
7. Chisolm SS, Taylor SL, Gryzwacz JG et al. (2010) Health behaviour models: A framework for studying adherence in children with atopic dermatitis. Clin Exp Dermatol 35:228-32
8. Chren MM, Lasek RJ, Flocke SA et al. (1997) Improved discriminative and evaluative capability of a refined version of Skindex, a qualityof-life instrument for patients with skin diseases. Arch Dermatol 133: 1433-40 (Pubitemid 27490569)
9. Chren MM, Sahay AP, Bertenthal DS et al. (2007) Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 127:1351-7 (Pubitemid 46762993)
10. Chren MM, Sahay AP, Sands LP et al. (2004) Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic. Med Care 42:1019-26 (Pubitemid 39530798)
11. Chren MM, Torres JS, Stuart SE et al. (2011) Recurrence after treatment of nonmelanoma skin cancer: A prospective cohort study. Arch Dermatol 147:540-6
12. Davis K, Schoen C, Stremikis K (2010) Mirror, mirror on the wall: How the performance of the US health care system compares internationally-2010 update. The Commonwealth Fund, June 2010. Available at /http://www.commonwealthfund.org/ ~/media/Files/Publications/Fund%20Report/2010/Jun/1400-Davis-Mirror-Mirror-on- the-wall-2010.pdfS
13. Dominguez PL, Husni ME, Holt EW et al. (2009) Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 301:573-9
14. Ellis CN, Drake LA, Prendergast MM et al. (2002) Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 46:361-70 (Pubitemid 34225399)
15. Essers BA, Dirksen CD, Nieman FH et al. (2006) Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 142:187-94 (Pubitemid 43276530)
16. Fears TR, Guerry DT, Pfeiffer RM et al. (2006) Identifying individuals at high risk of melanoma: A practical predictor of absolute risk. J Clin Oncol 24:3590-6 (Pubitemid 46630531)
17. Finlay AY, Khan GK (1994) Dermatology life quality index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-6 (Pubitemid 24194579)
18. Gawkrodger DJ (2011) Risk management in dermatology: An analysis of data available from several British-based reporting systems. Br J Dermatol 164:537-43
19. Geller AC, Zwirn J, Rutsch L et al. (2008) Multiple levels of influence in the adoption of sun protection policies in elementary schools in Massachusetts. Arch Dermatol 144:491-6 (Pubitemid 351581106)
20. Gershenwald JE, Soong SJ, Balch CM (2010) 2010 TNM staging system for cutaneous melanoma.and beyond. Ann Surg Oncol 17:1475-7
21. Gray BH, Gusmano MK, Collins SR (2003) AHCPR and the changing politics of health services research. Health Aff (Millwood). Suppl Web Exclusives:W3-283- 307
22. Hajjaj FM, Salek MS, Basra MK et al. (2010) Nonclinical influences, beyond diagnosis and severity, on clinical decision making in dermatology: Understanding the gap between guidelines and practice. Br J Dermatol 163:789-99
23. Hay RJ, Fuller LC (2011) The assessment of dermatological needs in resourcepoor regions. Int J Dermatol 50:552-7
24. Haynes B (1999) Can it work? Does it work? Is it worth it? The testing of healthcareinterventions is evolving. BMJ 319:652-3
25. Hernandez C, Cruz M, Robinson JK (2011) Spanish-speaking patient health educational preferences. Arch Dermatol 147:242-4
26. Hillhouse J, Turrisi R, Stapleton J et al. (2010) Effect of seasonal affective disorder and pathological tanning motives on efficacy of an appearancefocused intervention to prevent skin cancer. Arch Dermatol 146:485-91
27. Hu S, Parmet Y, Allen G et al. (2009) Disparity in melanoma: A trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol 145:1369-74
28. Kimball AB, Resneck Jr. JS (2008) The US dermatology workforce: A specialty remains in shortage. J Am Acad Dermatol 59:741-5
29. Kurd SK, Hoffstad OJ, Bilker WB et al. (2009) Evaluation of the use of prognostic information for the care of individuals with venous leg ulcers or diabetic neuropathic foot ulcers. Wound Repair Regen 17:318-25
30. Mayer JA, Slymen DJ, Clapp EJ et al. (2009) Long-term maintenance of a successful occupational sun safety intervention. Arch Dermatol 145:88-9
31. McKenna KE, Stern RS (1997) The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol 36:388-94 (Pubitemid 27131961)
32. Nijsten T, Looman CW, Stern RS (2007) Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol 143:1113-21 (Pubitemid 47443362)
33. Resneck Jr. JS, Isenstein A, Kimball AB (2006) Few Medicaid and uninsured patients are accessing dermatologists. J Am Acad Dermatol 55: 1084-8 (Pubitemid 44716485)
34. Robinson JK, Stapleton J, Turrisi R (2008) Relationship and partner moderator variables increase self-efficacy of performing skin self-examination. J Am Acad Dermatol 58:755-62
35. Sauaia A, Dellavalle RP (2009) Health care inequities: An introduction for dermatology providers. Dermatol Clin 27:103-7
36. Schmitt J, Langan S, Stamm T et al. (2011) Core outcome domains for controlled trials and clinical recordkeeping in eczema: International multiperspective Delphi consensus process. J Invest Dermatol 131: 623-30
37. Schmitt J, Langan S, Williams HC (2007) What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 120:1389-98 (Pubitemid 350216596)
38. Schmitt J, Williams H (2010) Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 163: 1166-8
39. Schofield JK, Grindlay D, Williams HC (2009) Skin conditions in the UK: A Health Care Needs Assessment. Nottingham, UK: Centre of Evidence Based Dermatology, University of Nottingham, UK
40. Seidler AM, Pennie ML, Veledar E et al. (2010) Economic burden of melanoma in the elderly population: Population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare data. Arch Dermatol 146:249-56
41. Stern RS (1990) Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med 322:1093-7 (Pubitemid 20149525)
42. Stern RS, Huibregtse A (2011) Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk. J Invest Dermatol 131:1159-66
43. Stern RS, Kleinerman RA, Parrish JA et al. (1980) Phototoxic reactions to photoactive drugs in patients treated with PUVA. Arch Dermatol 116:1269-71 (Pubitemid 11240901)
44. Stern RS, Nichols KT, Vakeva LH (1997) Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med 336:1041-5 (Pubitemid 27163855)
45. Stern RS, Thibodeau LA, Kleinerman RA et al. (1981) Effect of methoxsalen photochemotherapy on cost of treatment for psoriasis. An example of technological assessment. JAMA 245:1913-8 (Pubitemid 11099194)
46. Stern RS, Vakeva LH (1997) Noncutaneous malignant tumors in the PUVA follow-up study: 1975-1996. J Invest Dermatol 108:897-900 (Pubitemid 27272406)
47. Thomas KS, Keogh-Brown MR, Chalmers JR et al. (2006) Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts. An economic decision model. Health Technol Assess 10:iii, ix-87
48. Vargas III RB, Landon BE, Shapiro MF (2004) The future of health services research in academic medicine. Am J Med 116:503-7 (Pubitemid 38388627)
49. Warshaw EM, Hillman YJ, Greer NL et al. (2011) Teledermatology for diagnosis and management of skin conditions: A systematic review. J Am Acad Dermatol 64:759-72
50. Wich LG, Ma MW, Price LS et al. (2011) Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities. J Community Health 36:461-8